首页> 外国专利> Use of designer receptors exclusively activated by designer drugs in the treatment of seizure disorders

Use of designer receptors exclusively activated by designer drugs in the treatment of seizure disorders

机译:使用专门设计的药物激活的专门设计的受体来治疗癫痫发作

摘要

Administering to the patient a vector encoding the modified receptor for delivery of the modified receptor to the target location, where the modified receptor is modified to be activated by a synthetic ligand, where the modified receptor inhibits neuronal firing when activated. Making; And compositions and methods for treating seizure disorders comprising administering a synthetic ligand to a patient. The modified receptor is also modified to be activated by a synthetic ligand, where the modified receptor delivers a vector encoding the modified receptor to the patient for delivery of the modified receptor to the target site, which increases neuronal ignition when activated. ; And compositions and methods are provided for treating seizure disorders in a patient in need thereof by administering the synthetic ligand to the patient. Methods are used to alleviate or ameliorate one or more symptoms of a seizure disorder.
机译:向患者施用编码修饰受体的载体,用于将修饰受体递送至靶位置,其中修饰受体被修饰以被合成配体激活,其中修饰受体在激活时抑制神经元放电。制造;以及用于治疗癫痫症的组合物和方法,其包括向患者施用合成配体。修饰的受体也被修饰以被合成配体激活,其中修饰的受体将编码修饰的受体的载体递送至患者以将修饰的受体递送至靶位点,这在激活时增加神经元的着火。 ;并且提供了通过向患者施用合成配体来治疗有此需要的患者的癫痫发作的组合物和方法。方法用于缓解或改善癫痫发作的一种或多种症状。

著录项

  • 公开/公告号KR20190124309A

    专利类型

  • 公开/公告日2019-11-04

    原文格式PDF

  • 申请/专利权人 오비드 테라퓨틱스 인크.;

    申请/专利号KR20197030149

  • 发明设计人 듀링 매튜;

    申请日2018-03-15

  • 分类号A61K38/17;A61K31/55;A61K41;A61K9;A61P25/08;

  • 国家 KR

  • 入库时间 2022-08-21 11:49:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号